|
2024
|
Invention
|
Integrin inhibitor and uses thereof. Provided herein are crystalline forms of integrin inhibitors... |
|
|
Invention
|
Integrin inhibitor and uses thereof.
Provided herein are crystalline forms of integrin inhibitor... |
|
|
Invention
|
Methods of treatment comprising antibodies binding to alpha7beta1 integrin antibodies.
Disclosed... |
|
|
Invention
|
Amino acid compounds with nitrogen linkers and uses thereof. The present disclosure relates gener... |
|
|
Invention
|
Integrin inhibitors for treatment of primary sclerosing cholangitis.
The disclosure relates to m... |
|
|
Invention
|
Integrin inhibitors for treatment of primary sclerosing cholangitis. 616166 integrin inhibitors t... |
|
|
Invention
|
Amino acid compounds and methods of use.
The invention relates to compounds of formula (A) and f... |
|
|
Invention
|
Integrin inhibitor and uses thereof.
Provided herein are integrin inhibitors, compositions there... |
|
|
Invention
|
Biomarkers for use in integrin inhibitor therapy. The invention relates to methods of treating a ... |
|
2023
|
Invention
|
Alpha-v-beta-8 integrin inhibitors and uses thereof.
The disclosure relates to compounds of form... |
|
|
Invention
|
Alpha-v-beta-8 integrin inhibitors and uses thereof. The disclosure relates to compounds of formu... |
|
|
Invention
|
Substituted amino acids as integrin inhibitors.
The invention relates to compounds of formula (I... |
|
|
Invention
|
Amino acid compounds with unbranched linkers and methods of use.
The invention relates to compou... |
|
|
Invention
|
Integrin inhibitors and uses thereof in combination with other agents.
The invention relates to ... |
|
|
Invention
|
Integrin inhibitors and uses thereof in combination with other agents |
|
|
Invention
|
Integrin inhibitors and uses thereof in combination with other agents. The invention relates to m... |
|
|
Invention
|
Stabilization of integrin inhibitors. Provided herein are formulations comprising a hygroscopic o... |
|
|
Invention
|
N-acyl amino acid compounds and methods of use.
The invention relates to compounds of formula (I... |
|
|
Invention
|
Amino acid compounds and methods of use.
The invention relates to compounds of formula (I):
Th... |
|
2022
|
Invention
|
Therapeutic modulation of integrins. The invention relates methods of determining therapeutic dos... |
|
|
Invention
|
Therapeutic modulation of integrins.
The invention relates methods of determining therapeutic do... |
|
|
Invention
|
Dosage forms and regimens for amino acid compounds.
The invention relates to dosage forms for da... |
|
|
Invention
|
Expanded dosage regimens for integrin inhibitors.
The invention relates to dosage forms for dail... |
|
|
Invention
|
Expanded dosage regimens for integrin inhibitors. The invention relates to dosage forms for daily... |
|
|
Invention
|
Amino acid compounds with unbranched linkers and methods of use. The invention relates to compoun... |
|
2021
|
Invention
|
Integrin inhibitor and uses thereof. Provided herein are integrin inhibitors, compositions thereo... |
|
|
Invention
|
Crystalline forms of a salt of (s)-4-((2-methoxyyethyl)(4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-... |
|
|
Invention
|
Substituted amino acids as integrin inhibitors. The invention relates to compounds of formula (I)... |
|
|
Invention
|
Treatment of respiratory diseases with amino acid compounds.
The invention relates to methods of... |
|
|
Invention
|
Treatment of respiratory diseases with amino acid compounds. The invention relates to methods of ... |
|
2020
|
Invention
|
Combination treatment of liver diseases using integrin inhibitors.
The invention provides a phar... |
|
|
Invention
|
Combination treatment of liver diseases using integrin inhibitors. The invention provides a pharm... |
|
|
Invention
|
Combination treatment of liver diseases using integrin inhibitors. 11 integrin inhibitor and at l... |
|
|
Invention
|
Compositions and methods for activation of integrins. Disclosed herein are pharmaceutical agents ... |
|
|
Invention
|
Antibodies binding to α7β1 integrin antibodies and compositions thereof. Disclosed herein are pha... |
|
|
Invention
|
Amino acid compounds and methods of use. The invention relates to compounds of formula (A) and fo... |
|
|
Invention
|
Amino acid compounds and methods of use. The invention relates to compounds of formula (I):
8, X... |
|
|
Invention
|
N-acyl amino acid compounds and methods of use. The invention relates to compounds of formula (I)... |
|
2015
|
G/S
|
Pharmaceuticals for use in the treatment of fibrotic diseases, inflammatory diseases |
|
|
G/S
|
Research and development of pharmaceuticals for the treatment of fibrotic diseases, inflammatory ... |
